Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Hikma And Hargreaves Lansdown Lead FTSE 100 Higher

Fri, 07th Aug 2020 08:56

(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 managing to post mild gains after well-received earnings from Hikma Pharmaceuticals and Hargreaves Lansdown.

Investors were wary of US-China tensions after President Donald Trump signed an executive order barring US residents from doing any business with the Chinese parent companies of social media platforms TikTok and WeChat, citing national security concerns.

The UK flagship index was up 5.32 points, or 0.1%, at 6,032.26. The mid-cap FTSE 250 index was down 18.53 points, or 0.1%, at 17,460.85. The AIM All-Share index was flat at 916.53.

The Cboe UK 100 index was down 0.2% at 599.69. The Cboe 250 was down 0.3% at 14,828.68, and the Cboe Small Companies was flat at 9,212.65.

In mainland Europe, the CAC 40 in Paris was down 0.4%, while the DAX 30 in Frankfurt was off 0.1%.

"European markets surprisingly kept their cool on Friday morning, despite Donald Trump effectively banning TikTok and WeChat in the US. Giving companies 45 days to end all transactions with ByteDance and Tencent - the respective owners of the China-based apps - the president lobbed another tech grenade in his cold war with Beijing, almost guaranteeing some kind of retaliation from the rival superpower. But with the form and severity of that retaliation currently unknown, the markets managed to avoid a full-blown panic attack," commented Spreadex analyst Connor Campbell.

On the London Stock Exchange, Hikma Pharmaceuticals was the best blue-chip performer, up 7.0% after the generic drugmaker raised the annual sales outlook for its two main units and reported higher first-half profit.

For the half-year ended June 30, attributable profit came in at USD212 million, up 16% from USD185 million last year and revenue was USD1.13 billion, up 8% from USD1.05 billion.

Hikma said it expects 2020 revenue from the injectables business to be between USD950 million and USD980 million, from the previous forecast of growth in the low to mid-single digits.

In addition, Hikma raised the revenue outlook for its generics division to a range of USD720 million to USD760 million, from USD700 million to USD750 million previously.

Hikma raised its interim dividend 14% to 16.0 cents from 14.0 cents.

Hargreaves Lansdown was up 6.0% after the stockbroker said it delivered a strong annual performance, despite an external environment of persistent challenges.

The Bristol, England-based company, which offers an investment platform for retail investors, said assets under administration for the year to June 30 increased 5% year-on-year to GBP104.0 billion from GBP99.3 billion a year ago. Net new business inflows also rose 5% year-on-year to GBP7.7 billion from GBP7.3 billion.

Annual pretax profit jumped 24% to GBP378.3 million from GBP305.8 million profit a year ago. This included a gain on disposal of GBP38.8 million relating to FundsLibrary Ltd. Stripping out the exceptional disposal gain, pretax profit rose 11% year-on-year to GBP339.5 million.

Revenue rose 15% to GBP550.9 million from GBP480.5 million, driven by higher asset levels and record share dealing volumes seen in the second half of the year.

Following the strong performance, Hargreaves Lansdown raised its total dividend 11% to 54.9 pence from 42p.

Rightmove was up 4.0% as the property portal pointed to positive signs in the UK housing market going forward, despite posting a fall in interim profit.

Rightmove reported a drop in first-half profit and scrapped its dividend after the Covid-19 crisis prompted the property portal to offer discounts to its customers.

For the half-year to June 30, pretax profit dropped to GBP61.6 million, down from GBP108.1 million last year, as revenue fell to GBP94.8 million from GBP143.9 million. Average revenue per advertiser was down by 34% to GBP712 per month from GBP1,077 last year.

The company elected against paying an interim dividend, having paid out 2.8p last year.

However, Rightmove said stamp duty holidays offered by the UK government provided the potential for cautious optimism that housing transaction levels would increase from the low point in the second quarter.

"'Following the reopening of the housing market on 13 May housing market activity is at record levels, with evidence of new home hunters coming into the market with changing needs as they reassess their priorities and further incentivised by the temporary stamp duty holiday," Chief Executive Peter Brooks-Johnson said.

At the other end of the large-cap index, Rolls-Royce Holdings was down 2.0% after the Finacial Times reported US-based activist investor ValueAct sold its entire shareholding in the jet engine maker - citing two people familiar with the situation.

According to FT, ValueAct built a 10% stake in Rolls-Royce in 2015 after it issued a string of profit warnings. The UK engineering company is currently evaluating a GBP1.5 billion to GBP2 billion capital raise to help restore its balance sheet.

ValueAct started reducing its stake - which peaked in 2017 at 11% - after the departure of Rolls-Royce's chief operating officer Brad Singer in December.

The Japanese Nikkei 225 index closed down 0.4%. In China, the Shanghai Composite ended down 0.9%, while the Hang Seng index in Hong Kong is down 2.0%.

The pound was quoted at USD1.3107 Friday morning, lower from USD1.3137 at the London equities close Thursday. Sterling was easing from five-month highs versus the greenback attained after the Bank of England on Thursday said it was not planning to use negative interest rates in the immediate future.

The euro was priced at USD1.1838, soft from USD1.1845. Against the yen, the dollar was trading at JPY105.57, flat from JPY105.51 in London.

Brent oil was quoted at USD45.02 a barrel Friday morning, lower from USD45.37 at the London equities close Thursday.

Gold was priced at USD2,058.24 an ounce Friday, up from USD2,052.10 late Thursday.

Still to come, there is the closely-watched US jobs report for July at 1330 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.